SCHEMBL18248544

SCHEMBL18248544

CCCCC/C=C\C/C=C\CCCCCCC(Cc1ccccc1)C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 4/20 0.53
▸ FAAH O00519 4/20 0.53
▸ CNR1 P21554 2/20 0.53
▸ CNR2 P34972 1/20 0.53
▸ KDM4E B2RXH2 3/20 0.50
▸ SOAT1 P35610 1/20 0.50
▸ CSNK1E P49674 1/20 0.48
▸ ALDH1A1 P00352 4/20 0.47
▸ F7 P08709 3/20 0.47
▸ F3 P13726 3/20 0.47
▸ PPARG P37231 2/20 0.47
▸ PPARD Q03181 2/20 0.47
▸ PPARA Q07869 2/20 0.47
▸ DUSP3 P51452 1/20 0.47
▸ PTPN7 P35236 1/20 0.47
▸ FFAR1 O14842 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ FABP3 P05413 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP19A1 P11511 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18248575 0.97 FAAH (0.51) EPHX2FAAHCNR1CNR2CSNK1E
SCHEMBL11357056 0.97 FAAH (0.51) EPHX2FAAHCNR1CNR2CSNK1E
SCHEMBL18248569 0.97 FAAH (0.51) EPHX2FAAHCNR1CNR2CSNK1E
SCHEMBL18248593 0.94 EPHX2 (0.52) EPHX2FAAHCNR1CNR2KDM4E
SCHEMBL18248541 0.93 EPHX2 (0.53) EPHX2FAAHCNR1CNR2KDM4E
SCHEMBL31512495 0.90 EPHX2 (0.55) EPHX2FAAHCNR1CNR2KDM4E
SCHEMBL28058533 0.89 CSNK1E (0.57) CSNK1E
SCHEMBL22558568 0.89 CSNK1E (0.57) CSNK1E
SCHEMBL28081007 0.89 CSNK1E (0.57) CSNK1E
SCHEMBL7789683 0.89 CSNK1E (0.57) CSNK1E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110538170-B Application of macamides compound or salt thereof in preparation of medicine for preventing or treating hepatic fibrosis diseases 南华大学 2023-01-06 — — CN claimed
CN-110538170-A Application of macamides compound or salt thereof in preparation of medicine for preventing or treating hepatic fibrosis diseases UNIV SOUTH CHINA 2019-12-06 — — CN claimed
CN-110538170-B Application of macamides compound or salt thereof in preparation of medicine for preventing or treating hepatic fibrosis diseases 南华大学 2023-01-06 — — CN disclosed
CN-106723001-B Method for increasing content of amide in maca, prepared product and application of product 中国科学院过程工程研究所 2021-01-22 — — CN disclosed
CN-110538170-A Application of macamides compound or salt thereof in preparation of medicine for preventing or treating hepatic fibrosis diseases UNIV SOUTH CHINA 2019-12-06 — — CN disclosed
EP-3297621-A1 A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE Dublin City University (IE) 2018-03-28 — — EP disclosed
WO-2016185025-A1 A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE DUBLIN CITY UNIVERSITY (IE) 2016-11-24 — — WO disclosed
Send feedback